NMPA Approval

Ibrutinib Capsules

Approval Number

国药准字HJ20181066

Registration Date

January 30, 2022

Previous Approval Numbers

H20181066

Drug Information

Generic Name

伊布替尼胶囊

Trade Name

亿珂

Dosage Form

胶囊剂

Strength

140mg

Drug Type

化学药品

Registration Date

January 30, 2022

Expiry Date

January 29, 2027

Company Address

Turnhoutseweg 30,B-2340 Beerse

Company Address

10245 Hickman Mills Drive, Kansas City, MO 64137

Empowering clinical research with data-driven insights and AI-powered tools.

伊布替尼胶囊 - NMPA 批准文号 | MedPath